Sound Income Strategies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Sell
2,805
-71
-2% -$15.3K 0.03% 244
2026
Q1
$582K Buy
2,876
+282
+11% +$58.3K 0.03% 232
2025
Q4
$548K Buy
2,594
+2,593
+259,300% +$518K 0.03% 234
2025
Q3
$124 Hold
1
﹤0.01% 1618
2025
Q2
$107 Hold
1
﹤0.01% 1541
2025
Q1
$113 Hold
1
﹤0.01% 1495
2024
Q4
$110 Hold
1
﹤0.01% 1419
2024
Q3
$114 Hold
1
﹤0.01% 1360
2024
Q2
$102 Sell
1
-77
-99% -$11.6K ﹤0.01% 1332
2024
Q1
$11.9K Buy
78
+1
+1% +$152 ﹤0.01% 707
2023
Q4
$12.2K Buy
+77
New +$11.1K ﹤0.01% 694

Other funds holding FBT

Sound Income Strategies's FBT Position: Q2 2026 in Review

Sound Income Strategies reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.5% in Q2 2026, selling an estimated $15.3K and leaving 2,805 shares worth $695K. The position accounts for 0.03% of the portfolio, ranked #244.

Sound Income Strategies first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 267 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Sound Income Strategies held 2,805 shares of First Trust NYSE Arca Biotechnology Index Fund worth $695K as of Q2 2026.
  • Sound Income Strategies sold 71 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $15.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Sound Income Strategies's portfolio in Q2 2026, its #244 holding.
  • Sound Income Strategies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
  • 267 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.